dsip reddit Ion-Pair Speciation in Aqueous Alkali Fluorides from Nuclear Magnetic Resonance of 19F Want the FDA to Make

Studies of quadriceps muscle crush injuries demonstrate faster restoration of myotendinous junctions and reduced fibrosis at injury sites, preserving contractile function

Proposed mechanisms of GHK-Cu: GHK-Cu works largely through copper-dependent repair biology

On April 15, 2026 the FDA removed TB-500 (and 11 other peptides) from that Category 2 list

Here's a realistic timeline of what most patients experience during a BPC-157 protocol: Week 1-2 Early Response Reduced inflammation and pain at injection sites

The practical effect of longer duration is that trials can measure outcomes over weekly and multi week windows with consistent exposure, rather than focusing only on short time course endpoints